SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Josep Ordi-Ros, Francisco Javier Cosiglio, Indicaciones terapéuticas actuales de la talidomida y la lenalidomida, Medicina Clínica, 2014, 142, 8, 360

    CrossRef

  2. 2
    Isabelle Baret, Petra De Haes, Thalidomide: Still an important second-line treatment in refractory cutaneous lupus erythematosus?, Journal of Dermatological Treatment, 2014, 1

    CrossRef

  3. 3
    Mark G. Kirchhof, Jan P. Dutz, The Immunopathology of Cutaneous Lupus Erythematosus, Rheumatic Disease Clinics of North America, 2014, 40, 3, 455

    CrossRef

  4. 4
    Alisa N. Femia, Ruth Ann Vleugels, Jeffrey P. Callen, Cutaneous Dermatomyositis: An Updated Review of Treatment Options and Internal Associations, American Journal of Clinical Dermatology, 2013, 14, 4, 291

    CrossRef

  5. 5
    L.G. Okon, V.P. Werth, Cutaneous lupus erythematosus: Diagnosis and treatment, Best Practice & Research Clinical Rheumatology, 2013, 27, 3, 391

    CrossRef

  6. 6
    Isabel Bielsa Marsol, Indicaciones de talidomida y sus derivados en dermatología, Piel, 2013, 28, 10, 606

    CrossRef

  7. 7
    J Shortt, A K Hsu, R W Johnstone, Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy, Oncogene, 2013, 32, 36, 4191

    CrossRef

  8. 8
    Josep Ordi-Ros, Francisco Javier Cosiglio, Josefina Cortés-Henández, Tratamiento del lupus cutáneo con talidomida, Seminarios de la Fundación Española de Reumatología, 2013, 14, 2, 60

    CrossRef

  9. 9
    Yunyoung C. Chang, Victoria P. Werth, Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis, Current Dermatology Reports, 2013, 2, 1, 48

    CrossRef

  10. 10
    Emily D. Privette, Victoria P. Werth, Update on pathogenesis and treatment of CLE, Current Opinion in Rheumatology, 2013, 25, 5, 584

    CrossRef

  11. 11
    Didier Bessis, Lupus érythémateux, 2013,

    CrossRef

  12. 12
    Josefina Cortés-Hernández, Gabriela Ávila, Miquel Vilardell-Tarrés, Josep Ordi-Ros, Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus, Arthritis Research & Therapy, 2012, 14, 6, R265

    CrossRef